Retinal pigment epithelial cell loss assessed by fundus autofluorescence imaging in neovascular age-related macular degeneration

Ophthalmology

Volumn 120, Issue 2, 2013, Pages 334-341

  Kumar, Nishant ^a   Mrejen, Sarah ^a   Fung, Adrian Tien Chin ^a   Marsiglia, Marcela ^a   Loh, Boon K ^a   Spaide, Richard F ^a  

^a VITREOUS RETINA MACULA CONSULTANTS OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; PEGAPTANIB; RANIBIZUMAB;

AGED; ARTICLE; AUTOFLUORESCENCE IMAGING; CAMERA; CORNEAL ENDOTHELIAL CELL LOSS; DEMOGRAPHY; DISEASE COURSE; DISEASE DURATION; EYE EXAMINATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA LUTEA; VISUAL ACUITY;

AGED, 80 AND OVER; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; FUNDUS OCULI; HUMANS; MALE; PREVALENCE; RETINAL PIGMENT EPITHELIUM; RETROSPECTIVE STUDIES; VISUAL ACUITY; WET MACULAR DEGENERATION;

EID: 84873314716     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2012.07.076     Document Type: Article

References (46)

1. Eye Diseases Prevalence Research Group Prevalence of age-related macular degeneration in the United States Arch Ophthalmol 122 2004 564 572
2. J.P. Sarks, S.H. Sarks, M.C. Killingsworth Evolution of geographic atrophy of the retinal pigment epithelium Eye (Lond) 10 1988 552 577
3. J.S. Sunness, N.M. Bressler, Y. Tian Measuring geographic atrophy in advanced age-related macular degeneration Invest Ophthalmol Vis Sci 40 1999 1761 1769
4. A.P. Göbel, M. Fleckenstein, S. Schmitz-Valckenberg Imaging geographic atrophy in age-related macular degeneration Ophthalmologica 226 2011 182 190
5. R.F. Spaide Fundus autofluorescence and age-related macular degeneration Ophthalmology 110 2003 392 399
6. J.S. Sunness, M.D. Ziegler, C.A. Applegate Issues in quantifying atrophic macular disease using retinal autofluorescence Retina 26 2006 666 672
7. S. Schmitz-Valckenberg, F.G. Holz, A.C. Bird, R.F. Spaide Fundus autofluorescence imaging: review and perspectives Retina 28 2008 385 409
8. S. Bearelly, S.W. Cousins Fundus autofluorescence imaging in age-related macular degeneration and geographic atrophy Adv Exp Med Biol 664 2010 395 402
9. R.F. Spaide, D. Armstrong, R. Browne Continuing medical education review: choroidal neovascularization in age-related macular degeneration - what is the cause? Retina 23 2003 595 614
10. M.A. Zarbin Current concepts in the pathogenesis of age-related macular degeneration Arch Ophthalmol 122 2004 598 614
11. H.P. Scholl, M. Fleckenstein, P. Charbel Issa An update on the genetics of age-related macular degeneration Mol Vis [serial online] 13 2007 196 205 http://www.molvis.org/molvis/v13/a23/ Accessed June 24, 2012
12. H. Kaneko, S. Dridi, V. Tarallo DICER1 deficit induces Alu RNA toxicity in age-related macular degeneration Nature 471 2011 325 330
13. J. Sarks, K. Tang, M. Killingsworth Development of atrophy of the retinal pigment epithelium around disciform scars Br J Ophthalmol 90 2006 442 446
14. D.M. Brown, P.K. Kaiser, M. Michels ANCHOR Study Group Ranibizumab versus verteporfin for neovascular age-related macular degeneration N Engl J Med 355 2006 1432 1444
15. P.J. Rosenfeld, D.M. Brown, J.S. Heier MARINA Study Group Ranibizumab for neovascular age-related macular degeneration N Engl J Med 355 2006 1419 1431
16. D.M. Brown, M. Michels, P.K. Kaiser ANCHOR Study Group Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the ANCHOR Study Ophthalmology 116 2009 57 65
17. P.J. Rosenfeld, H. Shapiro, L. Tuomi MARINA and ANCHOR Study Group Characteristics of patients losing vision after 2 years of monthly dosing in the phase III ranibizumab clinical trials Ophthalmology 118 2011 523 530
18. Z. Yehoshua, P.J. Rosenfeld, G. Gregori Progression of geographic atrophy in age-related macular degeneration imaged with spectral domain optical coherence tomography Ophthalmology 118 2011 679 686
19. S. Schmitz-Valckenberg, F.G. Holz, A.C. Bird, R.F. Spaide Fundus autofluorescence imaging: review and perspectives Retina 28 2008 385 409
20. J.R. Sparrow, D. Hicks, C.P. Hamel The retinal pigment epithelium in health and disease Curr Mol Med 10 2010 802 823
21. F.C. Delori, C.K. Dorey, G. Staurenghi In vivo fluorescence of the ocular fundus exhibits retinal pigment epithelium lipofuscin characteristics Invest Ophthalmol Vis Sci 36 1995 718 729
22. S. Schmitz-Valckenberg, M. Fleckenstein, H.P. Scholl, F.G. Holz Fundus autofluorescence and progression of age-related macular degeneration Surv Ophthalmol 54 2009 96 117
23. N. Choudhry, A. Giani, J.W. Miller Fundus autofluorescence in geographic atrophy: a review Semin Ophthalmol 25 2010 206 213
24. A. von Rückmann, F.W. Fitzke, A.C. Bird Distribution of pigment epithelium autofluorescence in retinal disease state recorded in vivo and its change over time Graefes Arch Clin Exp Ophthalmol 237 1999 1 9
25. B. Lorenz, B. Wabbels, E. Wegscheider Lack of fundus autofluorescence to 488 nanometers from childhood on in patients with early-onset severe retinal dystrophy associated with mutations in RPE65 Ophthalmology 111 2004 1585 1594
26. U. Kellner, A.B. Renner, H. Tillack Fundus autofluorescence and mfERG for early detection of retinal alterations in patients using chloroquine/ hydroxychloroquine Invest Ophthalmol Vis Sci 47 2006 3531 3538
27. M.S. Mustafa, V.A. McBain, C.M. Scott Autofluorescence imaging - a useful adjunct in imaging macular trauma Clin Ophthalmol 4 2010 1497 1498
28. Y. Imamura, T. Fujiwara, R.F. Spaide Fundus autofluorescence and visual acuity in central serous chorioretinopathy Ophthalmology 118 2011 700 705
29. A.G. Robson, A. Tufail, F. Fitzke Serial imaging and structure-function correlates of high-density rings of fundus autofluorescence in retinitis pigmentosa Retina 31 2011 1670 1679
30. R.H. Roe, J.M. Jumper, V. Gualino Retinal pigment epitheliopathy, macular telangiectasis, and intraretinal crystal deposits in HIV-positive patients receiving ritonavir Retina 31 2011 559 565
31. T. Sepp, J.C. Khan, D.A. Thurlby Complement factor H variant Y402H is a major risk determinant for geographic atrophy and choroidal neovascularization in smokers and nonsmokers Invest Ophthalmol Vis Sci 47 2006 536 540
32. D.J. Cameron, Z. Yang, D. Gibbs HTRA1 variant confers similar risks to geographic atrophy and neovascular age-related macular degeneration Cell Cycle 6 2007 1122 1125
33. W. Smith, J. Assink, R. Klein Risk factors for age-related macular degeneration: pooled findings from three continents Ophthalmology 108 2001 697 704
34. D. Husain, M. Kramer, A.G. Kenny Effects of photodynamic therapy using verteporfin on experimental choroidal neovascularization and normal retina and choroid up to 7 weeks after treatment Invest Ophthalmol Vis Sci 40 1999 2322 2331
35. J.W. Miller, A.W. Walsh, M. Kramer Photodynamic therapy of experimental choroidal neovascularization using lipoprotein-delivered benzoporphyrin Arch Ophthalmol 113 1995 810 818
36. S.J. Bakri, J.D. Cameron, C.A. McCannel Absence of histologic retinal toxicity of intravitreal bevacizumab in a rabbit model Am J Ophthalmol 142 2006 162 164
37. L. Feiner, E.E. Barr, Y.B. Shui Safety of intravitreal injection of bevacizumab in rabbit eyes Retina 26 2006 882 888
38. S.H. Byeon, S.C. Lee, S.H. Choi Vascular endothelial growth factor as an autocrine survival factor for retinal pigment epithelial cells under oxidative stress via the VEGF-R2/PI3K/Akt Invest Ophthalmol Vis Sci 51 2010 1190 1197
39. Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group Writing Committee D.F. Martin, M.G. Maguire, S.L. Fine et al. Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results Ophthalmology 119 2012 1389 1398
40. A.C. Bird, N.M. Bressler, S.B. Bressler International ARM Epidemiological Study Group An international classification and grading system for age-related maculopathy and age-related macular degeneration Surv Ophthalmol 39 1995 367 374
41. C.C. Klaver, J.J. Assink, R. van Leeuwen Incidence and progression rates of age-related maculopathy: the Rotterdam Study Invest Ophthalmol Vis Sci 42 2001 2237 2241
42. Age-Related Eye Disease Study Research Group The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS report no. 17 Arch Ophthalmol 123 2005 1484 1498
43. J.M. Seddon, S. Sharma, R.A. Adelman Evaluation of the clinical age-related maculopathy staging system Ophthalmology 113 2006 260 266
44. P.K. Kaiser, D.M. Brown, K. Zhang Ranibizumab for predominantly classic neovascular age-related macular degeneration: subgroup analysis of first-year ANCHOR results Am J Ophthalmol 144 2007 850 857
45. CATT Research Group D.F. Martin, M.G. Maguire, G.S. Ying et al. Ranibizumab and bevacizumab for neovascular age-related macular degeneration N Engl J Med 364 2011 1897 1908
46. C.M. Mangione, P.P. Lee, P.R. Gutierrez National Eye Institute Visual Function Questionnaire Field Test Investigators Development of the 25-item National Eye Institute Visual Function Questionnaire Arch Ophthalmol 119 2001 1050 1058